ISRG

ISRG

Intuitive Surgical

Medtech / Consumables

★ Quality 68/100
Overvalued

Price today

$366.70

This company value is already calculated

We know what it is worth from its audited numbers, and whether it trades above or below that today. Create your free account to see it.

See what it is worth

charlieapp.co

🏆

A monopoly position

This company has a competitive advantage so strong that its rivals find it practically impossible to replicate.

What this business is made of

68qualityReturnsMoatBalance sheetPricing power *Reinvestment
* That figure exists but does not describe this company, so the axis is left out of the score.

The business

Sells the razor at cost; the fortune is in the blades.

Intuitive Surgical makes and sells the da Vinci robotic surgical system. The system is the hook; the recurring money comes from disposable instruments, accessories, and service — about 80% of 2025's $10.1B in revenue. Every procedure burns through parts the hospital buys again.

Over 9,500 installed systems create brutal switching costs: the surgeon trains for years on da Vinci and the hospital amortizes a machine worth millions. Decades of procedure data and thousands of patents raise the wall. Zero debt and 66% gross margin leave room to defend it.

Revenue history

$5.7B
2021
$6.2B
2022
$7.1B
2023
$8.4B
2024
$10.1B
2025
CAGR 5 años: +15%

From $5.7B to $10.1B in 4 years. The business grows steadily.

Where each $100 of sales goes

Revenue $10.1B · FY2025

Cost of sales$3.4B · 34%
Operations$3.7B · 37%
Taxes and other$90M · <1%
Net profit$2.9B · 28%

Of every $100 in sales, $72 goes to costs and operations; $28 is left as net profit (28% margin).

Catalysts and risks

Rollout of the da Vinci 5 (launched 2024) accelerating system sales in 2026.

Double-digit annual procedure growth, installed base topping 10,000 systems.

International expansion, especially India and emerging markets with low robotic penetration.

⚠️

Demanding valuation: the market pays for decades of growth up front, little room for error.

⚠️

Competition waking up — Medtronic Hugo and J&J Ottava looking to take a bite of the share.

⚠️

Dependence on hospital capital budgets; in a recession, systems get postponed.

Charlie's note

A surgical toll booth with zero debt and monopoly margins — the kind of business you want to hold for twenty years. The only problem is the price: it trades well above what an old cheapskate would pay.

Analysis · June 2026

Want to follow Intuitive Surgical?

We do not calculate a value here: Intuitive Surgical does not generate cash flows you can project, and putting a number on it would be making it up. What you can do is follow it and tell us the price you care about — we will email you when it gets there.

🔔 Email me

Free · no card

Charlie informs, it doesn't advise. No information should be taken as a recommendation to buy or sell.